Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

References

• KremersHMCrowsonCSTherneauTMRogerVLGabrielSEHigh ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort studyArthritis Rheum20085882268227418668561
   PubMed Web of Science ®Google Scholar
• Aviña-ZubietaJAChoiHKSadatsafaviMElminanJMEsdaileJMLacailleDRisk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studiesArthritis Rheum200859121690169719035419
   PubMed Web of Science ®Google Scholar
• SolomonDHGoodsonNJKatzJNPatterns of cardiovascular risk in rheumatoid arthritisAnn Rheum Dis200665121608161216793844
   PubMed Web of Science ®Google Scholar
• Maradit-KremersHNicolaPJCrowsonCSBallmanKVGabrielSECardiovascular death in rheumatoid arthritis: a population-based studyArthritis Rheum200552372273215751097
   PubMed Web of Science ®Google Scholar
• SolomonDHKarlsonEWRimmEBCardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritisCirculation200310791303130712628952
   PubMed Web of Science ®Google Scholar
• del RincónIDWilliamsKSternMPFreemanGLEscalanteAHigh incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsArthritis Rheum200144122737274511762933
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudKThe risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysisArthritis Rheum20085892612262118759273
   PubMed Web of Science ®Google Scholar
• Del RincónIWilliamsKSternMPFreemanGLO’LearyDHEscalanteAAssociation between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjectsArthritis Rheum20034871833184012847676
   PubMed Web of Science ®Google Scholar
• GoodsonNJSymmonsDPScottDGBunnDLuntMSilmanAJBaseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohortArthritis Rheum20055282293229916052597
   PubMed Web of Science ®Google Scholar
• Van DoornumSMcCollGWicksIPAccelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?Arthritis Rheum200246486287311953961
   PubMed Web of Science ®Google Scholar
• VitaJAKeaneyJFJrEndothelial function: a barometer for cardiovascular risk?Circulation2002106664064212163419
   PubMed Web of Science ®Google Scholar
• Gonzalez-JuanateyCTestaAGarcia-CasteloAHLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritisAm J Med2003114864765212798452
   PubMed Web of Science ®Google Scholar
• Gonzalez-JuanateyCTestaAGarcia-CasteloAGarcia-PorruaCLlorcaJGonzalez-GayMAActive but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibodyArthritis Rheum200451344745015188332
   PubMed Web of Science ®Google Scholar
• CohenSBEmeryPGreenwaldMWthe REFLEX Trial GroupRituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeksArthritis Rheum20065492793280616947627
   PubMed Web of Science ®Google Scholar
• KeystoneEEmeryPPeterfyCGRituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapiesAnn Rheum Dis200968221622118388156
   PubMed Web of Science ®Google Scholar
• BenucciMManfrediMPuttiniPCAtzeniFPredictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?Autoimmun Rev201091280180320656069
   PubMed Web of Science ®Google Scholar
• ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum19883133153243358796
   PubMed Web of Science ®Google Scholar
• RitchieDMBoyleJAMcInnesJMClinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritisQJMed196837147393406
   Google Scholar
• FransenJvan RielPLThe disease activity score and EULAR response criteriaClin Exp Rheumatol2005235 suppl 39939515789894
   PubMed Web of Science ®Google Scholar
• RanzaRMarchesoniACaloriGThe Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies in rheumatoid arthritisClin Exp Rheumatol19931121231288508554
   PubMed Web of Science ®Google Scholar
• KerekesGSzekaneczZDérHEndothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunityJ Rheumatol200835339840618203326
   PubMed Web of Science ®Google Scholar
• SellamJHendel-ChavezHRouanetSB cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label studyArthritis Rheum201163493393821225699
   PubMed Web of Science ®Google Scholar
• Sarzi-PuttiniPAtzeniFGerliRCardiac involvement in systemic rheumatic diseases: An updateAutoimmun Rev201091284985220692379
   PubMed Web of Science ®Google Scholar
• GerliRVaudoGBocciEBFunctional impairment of arterial wall in primary Sjögren’s syndrome: combined action of immunological and inflammatory factorsArthritis Care Res (Hoboken)201062571271820191479
   PubMed Web of Science ®Google Scholar
• KokkonenHSöderströmIRocklövJHallmansGLejonKRantapää DahlqvistSUp-regulation of cytokines and chemokines predates the onset of rheumatoid arthritisArthritis Rheum201062238339120112361
   PubMed Web of Science ®Google Scholar
• AtzeniFTurielMCaporaliRThe effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseasesAutoimmun Rev201091283583920678592
   PubMed Web of Science ®Google Scholar
• KerekesGSoltészPDérHEffects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritisClin Rheumatol200928670571019319624
   PubMed Web of Science ®Google Scholar
• Gonzalez-JuanateyCLlorcaJVazquez-RodriguezTRDiaz-VarelaNGarcia-QuirogaHGonzalez-GayMAShort-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapyArthritis Rheum200859121821182419035415
   PubMed Web of Science ®Google Scholar
• Ait-OufellaHHerbinOBouazizJDB cell depletion reduces the development of atherosclerosis in miceExp Med2010207815791587
   PubMed Web of Science ®Google Scholar
• KyawTTayCKhanAConventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosisJ Immunol201018574410441920817865
   PubMed Web of Science ®Google Scholar
• Van LeeuwenMDamoiseauxJDuijvestijnATervaertJWThe therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosisAutoimmun Rev200991535719285155
   PubMed Web of Science ®Google Scholar
• TremblayMSColleyRCSaundersTJHealyGNOwenNPhysiological and health implications of a sedentary lifestyleAppl Physiol Nutr Metab201035672574021164543
   PubMed Web of Science ®Google Scholar
• Ait-OufellaHTalebSMallatZTedguiARecent advances on the role of cytokines in atherosclerosisArterioscler Thromb Vasc Biol201131596997921508343
   PubMed Web of Science ®Google Scholar
• van VollenhovenRFEmeryPBinghamCO3rdLongterm safety of patients receiving rituximab in rheumatoid arthritis clinical trialsJ Rheumatol201037355856720110520
   PubMed Web of Science ®Google Scholar